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Abstract
Background: To assess the acceptability of intrapartum HIV testing and determine the prevalence
of HIV among labouring women with unknown HIV status in Cameroon.
Method: The study was conducted in four hospitals (two referral and two districts hospitals) in
Cameroon. Labouring women with unknown HIV status were counselled and those who accepted
were tested for HIV.
Results: A total of 2413 women were counselled and 2130 (88.3%) accepted to be tested for HIV.
Of the 2130 women tested, 214 (10.1%) were HIV positive. Acceptability of HIV testing during
labour was negatively associated with maternal age, parity and number of antenatal visits, but
positively associated with level of education. HIV sero-status was positively associated with
maternal age, parity, number of antenatal visits and level education.
Conclusion: Acceptability of intrapartum HIV testing is high and the prevalence of HIV is also high
among women with unknown HIV sero-status in Cameroon. We recommend an opt-out approach
(where women are informed that HIV testing will be routine during labour if HIV status is unknown
but each person may decline to be tested) for Cameroon and countries with similar social profiles.
Background
About 3.2 million infants and young children worldwide
are infected with Human Immunodeficiency Virus (HIV)
and more than 95% of them get the virus from their
mother, usually during the intrapartum period [1,2]. The
traditional method for preventing mother-to-child trans-
mission (MTCT) of HIV is voluntary testing during ante-
natal care and provision of antiretroviral prophylaxis to
the HIV-infected women and their newborns [3,4].
The World Health Organisation estimates that in develop-
ing countries, 32% of pregnant women give birth with no
previous antenatal care [5]. Although universal antenatal
HIV testing is standard in the USA, an estimated 40% of
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whose HIV infection was unrecognized [6]. In settings
where many women give birth with unknown HIV status
either because of low antenatal attendance or otherwise,
HIV testing during labour provides the last window of
opportunity before delivery for interventions to reduce
MTCT of HIV [7,8].
A recent study in the USA reported that out of 190 labour-
ing women who underwent rapid HIV testing, 7 were
found positive. On subsequent testing of the seven HIV
positive women by Western Blot, 3 were confirmed posi-
tive, 2 were found negative and the results of 2 remained
indeterminate [6]. In this study the sensitivity of rapid
HIV testing was 100%, specificity 97.9%, positive predic-
tive value (PPV) 42.9%, and negative predictive value
100%. The authors suggested that availability of rapid
HIV testing on labour and delivery units should not
replace rigorous prenatal screening, which is currently the
standard method screening for HIV during pregnancy. A
two-step rapid HIV testing, particularly parallel testing,
has been reported to be superior to single test strategy and
is comparable to standard testing [4].
Acceptability of rapid intrapartum HIV testing varies from
83% to 97% depending on the study setting [4]. Homsy
and colleagues in 2006 reported that 86% of labouring
women in Tanzania accepted intrapartum HIV testing [9].
Malonza and colleagues (2003) compared rapid HIV test-
ing and conventional HIV testing during antenatal care
with respect to the percentage women who received their
HIV test results in Kenya [10]. They found that 96% of
women who had rapid HIV testing received their results
compared to 73% of women who had conventional HIV
testing.
Cameroon is one of the sub-Saharan African countries
with high HIV prevalence (6.8% among women of repro-
ductive age) [11]. In Cameroon, one in every five pregnant
women do not receive antenatal care during pregnancy,
meaning that traditional HIV testing during antenatal care
cannot capture a sizeable proportion of women [11]. Of
all women who attend antenatal care 92% accept HIV test-
ing [12]. The objective of this study was to assess the
acceptability of HIV testing among women who come in
labour with unknown HIV status. This is the first study to
evaluate the acceptability of intrapartum HIV counselling
and testing in Cameroon.
Methods
The study was conducted in two referral hospitals
(Yaounde University Hospital Centre and Yaounde Cen-
tral Maternity) and two district hospitals (Biyem-Assi and
Cite Verte) between January 2004 and December 2005.
All the four hospitals are located in the capital city,
Yaounde. Both referral and district hospitals were chosen
for this study in order to have a mix of labouring women
who were representative of the capital city. The study was
approved by the Ethics Committee of the Faculty of Med-
icine and Biomedical Sciences (University of Yaounde I).
All labouring women (except those in the second stage of
labour) with unknown HIV status presenting to the
labour room during the study period were eligible for
inclusion in the study. No woman with unknown HIV sta-
tus arrived in the second stage of labour. HIV counseling
and testing was offered by a trained counselor and a labo-
ratory technician round the clock. Counselors were mid-
wives trained on appropriate counseling techniques and
laboratory technicians were technicians who normally
work in the hospitals; so there was no extra cost of recruit-
ing new staff. Before the study started counselors were
briefed about the study but did not receive any additional
training. The basic elements of counseling were respected
namely that clients understand: (i) the clinical and pre-
vention benefits of testing, (ii) the right to refuse, (iii) the
follow up services that will be offered, and (iv) the impor-
tance of sharing results with a partner in case of positive
results. HIV positive women receive standard Nevirapine
mono-therapy prophylaxis regimen immediately and
their babies receive Nevirapine syrup.
We used rapid tests to screen for HIV. HIV was screened
initially with Determine (Abbott Laboratories, IL, USA)
and with Capillus (Trinity Biotec Plc, Wicklow, Ireland).
When the results of the two tests were inconsistent, Uni-
gold (Trinity Biotec Plc, Wicklow, Ireland) was used as tie-
breaker. The results were disclosed to the patients within
the shortest convenient time during a post-test coun-
seling. Women tested HIV positive received psychological
and social support through the labour from the counselor.
Screens were used to ensure privacy and confidentiality.
Data was entered into SPSS Version 13. Descriptive statis-
tics such as proportions were analysed and presented.
Univariate analyses, using unadjusted odds ratios (OR)
and Chi-square test for association, were conducted to
assess the association between variables. Finally, multiple
logistic regression analyses were then carried out and the
results reported as adjusted ORs. Independent variables
entered into the logistic models were age, parity, number
of antenatal visits, marital status and level of education.
All significance tests were two-tailed and statistical signif-
icance was defined at the 5% alpha level.
Results
A total of 8043 pregnant women (2803 for Yaounde Cen-
tral Hospital, 2510 for Yaounde University Hospital Cen-
tre, 1423 for Biyem-Assi District Hospital and 1307 for
Cite Verte District Hospital) gave birth during the studyPage 2 of 6
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done during pregnancy. All the 2413 women were coun-
seled and 2130 (88.3%) accepted to be tested for HIV. Of
the 2130 tested for HIV, 214 (10.05%) were HIV positive.
Socio-demographic characteristics of study participants
Socio-demographic characteristics of the study partici-
pants are shown in Table 1. The mean age was 27 years
(standard deviation [SD] = 8.5; range 15 to 45). A major-
ity (57%) of the women were aged 20–29 years. Twenty
one percent (21%) were nulliparous women, while 37.5%
had four previous deliveries or more. More than 80% of
women had at least one antenatal visit during their index
pregnancy. Most of them were married (58%) and had
secondary education or higher (57.2%).
Acceptability of HIV testing
The associations between selected characteristics and
acceptability of HIV testing of the study participants are
presented in Table 2. Compared to younger women (< 20
years), women aged 20–29 years were 1.5 times (odds
ratios [OR] = 0.68, confidence interval [CI] 0.46–0.97)
and women aged ≥30 years 2 times (OR = 0.47, CI 0.34–
0.73) more likely to refuse HIV testing in the labour room.
Compared to nulliparous women, parous women were
1.6 times (OR = 0.63, CI 0.44–0.89) more likely to refuse
HIV testing after counseling. Women who did not receive
any antenatal care during their pregnancy were more
likely to accept HIV testing than those who attended ante-
natal clinics 1–2 times (OR = 0.42, CI 0.26–0.66) or ≥3
times (OR = 0.49, CI 0.33–0.72). Compared to women
with no formal education, women with primary educa-
tion were 1.2 times (OR = 1.20, CI 0.81–1.86) and
women with secondary education or higher were 1.7
times (OR = 1.65, CI 1.10–2.42) more likely to accept HIV
testing after counseling. There was no significant associa-
tion between acceptability of HIV testing and marital sta-
tus
Overall, acceptability of HIV testing in the labour room
was negatively associated with maternal age, parity and
number of antenatal visits, but positively associated with
level of education. The main reasons for refusal of rapid
HIV testing were fear of stigma (35.3%), discrimination
(29.3%), rejection (15.9%) and no reason specific reason
or reason reserved (19.4%).
Prevalence of HIV
Of the 2130 women tested for HIV, 214 were HIV posi-
tive, giving an overall HIV prevalence of 10.1% among
labouring women with unknown HIV status.
The associations between selected characteristics and HIV
status are presented in Table 3. Compared to younger
women (< 20 years), older women (≥30 years) were more
likely to be HIV positive (p = 0.035). Parous women also
more likely to be HIV positive when compared to nullipa-
rous women. Women who did not receive any antenatal
care during their pregnancy were less likely to be HIV pos-
itive. Compared to women with no formal education,
women with secondary education were more likely to be
HIV positive (p = 0.006).
Overall, the HIV status was positively associated with
maternal age, parity, number of antenatal visits and level
of education. There was no significant association
between marital status and HIV results.
Discussion
This study assessed the acceptability of HIV testing and
prevalence of HIV among women who come in labour
with unknown HIV status. The overall acceptability was
high (88.3%) and 10.0% of those tested were HIV posi-
tive. Bulterys (2004) reported that 84% of women
accepted HIV testing during labour in the USA [7]. Homsy
(2006) reported an acceptability rate of 86% in Uganda
[9] and Bharucha (2005) reported a lower acceptability
rate (40%) in India [8]. These differences in acceptability
may be explained by socio-economic and cultural differ-
ences as well as differences in perceived risk of HIV infec-
tion. Some reasons given by women for refusing HIV
testing in our study were fear of stigma, discrimination
and rejection. These reasons may vary between different
socio-economic and cultural strata.
The overall HIV prevalence in our study was 10.1%. This
prevalence is higher than 6.8% among women of repro-
Table 1: Socio-demographic characteristics of study population
Characteristic Number Percentage (%)
(N = 2413)
Age
< 20 years 493 20.4
20–29 years 1375 57.0













No formal education 249 10.3
Primary 787 32.5
Secondary or higher 1380 57.2Page 3 of 6
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known HIV status [13] in Cameroon. Viani (2006) also
reported a higher HIV prevalence among women screened
during labour (1.12%) than women screened during ante-
natal care (0.33%) [14]. This suggests that compared to
HIV negative women, HIV positive women are less likely
have a known HIV status during labour. This highlights
the importance of HIV testing during labour and provi-
sion of antiretroviral prophylaxis against MTCT of HIV.
We used parallel testing for HIV. A systematic review of lit-
erature of rapid point-of-care HIV testing in pregnant
women found this method of HIV testing to be superior
to a single testing strategy with regards to sensitivity and
specificity [4].
Table 2: Characteristics of women counselled in labour room by acceptability of HIV testing.






Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value
Age
< 20 years 445 (20.9) 38 (13.4) 1 1
20–29 years 1214 (57.0) 161(56.9) 0.66 (0.45–0.95) 0.68 (0.46–0.97) 0.026
≥30 years 461 (21.6) 84(29.7) 0.46 (0.30–0.68) 0.47 (0.34–0.73) < 0.001
Parity
0 467(29.9) 40(14.1) 1 1
1–3 874(41.0) 127(44.9) 0.59 (0.40–0.85) 0.63 (0.44–0.89) 0.005
≥4 789(37.0) 116(41.0) 0.58 (0.40–0.85) 0.60 (0.34–0.73) 0.004
No of antenatal visits
0 441(20.7) 30(10.6) 1 1
1–2 582(27.3) 94(33.2) 0.42 (0.27–0.64) 0.42 (0.26–0.66) < 0.001
≥3 1107(52.0) 159(56.2) 0.47 (0.31–0.70) 0.49 (0.33–0.72) < 0.001
Marital status
Single 894(42.0) 119(42.0) 1 1
Married 1236(58.0) 164(58.0) 1.00 (0.78–1.29) 1.00 (0.75–1.26) 0.980
Education
No formal education 209(9.8) 40(14.1) 1 1
Primary 682(32.0) 102(36.0) 1.28 (0.85–1.90) 1.20 (0.81–1.86) 0.225
Secondary or higher 1239(58.2) 141(49.8) 1.68 (1.14–2.45) 1.65 (1.10–2.42) 0.010









Adjusted OR (95% CI) p-value
Age
< 20 years 36(16.8) 419(21.9) 1 1
20–29 years 127(59.3) 1087(56.7) 1.36 (0.93–2.02) 1.33 (0.90–2.00) 0.127
≥30 years 56(26.2) 405(21.1) 1.61 (1.04–2.52) 1.58 (1.02–2.50) 0.032
Parity
0 37(17.3) 430(22.4) 1 1
1–3 103(48.1) 771(40.2) 1.55 (1.05–2.32) 1.51 (1.03–2.29) 0.028
≥4 74(34.6) 715(37.3) 1.20 (0.80–1.83) 1.10 (0.79–1.80) 0.383
No of antenatal visits
0 29(13.6) 412(21.5) 1 1
1–2 64(29.9) 518(27.0) 1.76 (1.12–2.80) 1.71 (1.09–2.75) 0.013
≥3 121(56.5) 986(51.5) 1.74 (1.15–2.69) 1.70 (1.11–2.65) 0.009
Marital status
Single 85(39.7) 809(42.2) 1 1
Married 129(60.3) 1107(57.8) 1.11 (0.83–1.48) 1.11 (0.81–1.49) 0.481
Education
No formal education 11(5.1) 198(10.3) 1 1
Primary 63(29.4) 619(32.3) 1.83 (0.97–3.71) 1.80 (0.95–3.67) 0.074
Secondary or higher 140(65.4) 1099(57.4) 2.29 (1.26–4.52) 2.24 (1.22–4.49) 0.006Page 4 of 6
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of HIV testing during labour on one hand, and maternal
age and number of antenatal visits on the other hand. This
has been reported previously [7]. Some women who had
antenatal care with unknown HIV status had previously
refused HIV testing and were therefore less likely to accept
HIV testing compared to women who were counseled for
the first time. Educated women were more likely to accept
HIV counseling and testing than women who had no for-
mal education. Educated and uneducated women may
differ in their perceived risk of HIV and understanding of
the importance HIV testing. For example in one study,
educated women were less likely to believe that HIV truly
exists, compared to their uneducated counterparts [15].
Wealth and education have been reported to be positively
correlated with unsafe sexual behaviour in Cameroon
[16]
Voluntary HIV counseling and testing in the delivery
room is a challenging task especially in resource-con-
straint settings because insufficient number of trained
staff, and inadequate resources [17]. There is need to have
round-the-clock services including laboratory technicians,
trained counsellors and access to HIV test kits. Despite
these challenges, HIV counseling and testing in delivery
room is feasible in both low, medium and high-income
countries [7,8]. Wright (2000) suggested that the decision
to implement HIV testing in delivery room should depend
on the HIV prevalence, access to health facilities, availabil-
ity of resources, access to delivery skilled health person-
nel, and cooperation of hospital staff and administrators
[18]. The cost of rapid HIV testing in our study was 4 UD$
per person tested.
Other internationally recommended regimens for PMTCT
of HIV have superseded Nevirapine alone. World Health
Organisation currently recommends two types of regi-
mens [19]: (a) Antiretroviral Therapy if CD4 count is <
200/mm3 irrespective of the WHO Clinical Stage or CD4
count < 350/mm3 plus Clinical Stage 3 or 4 – Zidovudine
(AZT) + Lamivudine (3TC) + Nevirapine (NVP) twice
daily to women during antepartum, intrapartum and
postpartum period and AZT for 7 days to infant; (b)
Antiretroviral Prophylaxis where women are given AZT
after 28 weeks of pregnancy or as soon as possible there-
after, NVP + AZT/3TC during labour, AZT/3TC for 7 days
postpartum and infants are given NVP + AZT for 7 days.
All the antiretroviral drugs recommended by the WHO for
prevention of mother-to-child transmission of HIV are
available for free to all pregnant women in the four hospi-
tals included in this study. Pregnant women with positive
HIV and their infants are put on the appropriate treat-
ment. Therefore intrapartum HIV testing in Cameroon
will reduce the number of women who give birth with
unknown HIV status and the number of mother-infant
pairs who receive treatment for preventing mother-to-
child transmission of HIV.
All the four hospitals included in our study are located in
the Centre Province in Cameroon and therefore do not
accurately represent the whole country. There is need for
future research to assess the acceptability of intrapartum
HIV testing and counselling in rural areas in Cameroon in
order to get a complete picture in the country. In addition,
this study did not evaluate the cost-effectiveness of intra-
partum HIV counselling and testing. Before the approach
is implemented nationwide, it will be important to evalu-
ate the cost-effective of this approach.
Conclusion
We conclude that HIV prevalence among in labour with
unknown HIV status is high, and fortunately enough
acceptability for HIV testing during labour is also high.
We recommend an opt-out approach for HIV testing dur-
ing labour in Cameroon (i.e. women are informed that
HIV testing will be routine during labour if HIV status is
unknown but each person may decline to be tested). An
opt-out approach will decrease the proportion of women
who give birth with unknown HIV status and increase the
number of mother-infant pairs who receive appropriate
treatment for preventing mother-to-child transmission of
HIV. Bharucha (2004) suggested postpartum counseling
and testing of women who refused HIV testing during
labour [8]. During the postpartum period women might
be better physically and mentally to understand and
accept counseling and testing. It might be worthwhile to
consider postpartum counseling and testing in settings
where HIV prevalence is high. Hospitals with over 10,000
deliveries per year might consider recruiting extra staff to
conduct counselling and HIV testing if the maternity staff
are faced with high volume of work.
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